Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) Director Joanna Horobin sold 8,500 shares of the stock in a transaction on Friday, June 7th. The shares were sold at an average price of $32.99, for a total value of $280,415.00. The sale was disclosed in a filing with the SEC, which is available through the […]
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) major shareholder Real Estate Equitie Alexandria sold 150,000 shares of Applied Therapeutics stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $4.21, for a total value of $631,500.00. Following the completion of the transaction, the insider now directly owns […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) Director Jay Lichter sold 1,500,000 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $54.75, for a total transaction of $82,125,000.00. Following the sale, the director now directly owns 633,673 shares of the company’s stock, […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2024 earnings per share estimates for Tango Therapeutics in a research note issued to investors on Tuesday, May 28th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings of ($0.36) per share for the quarter, […]
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned an average rating of “Buy” from the nine brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]